Pandemic Management

Vaccine Sovereignty as a Strategy for the UK’s Future Health, Wealth and National Security

| 27th February 2026

UK investment in vaccine sovereignty will ensure a rapid response to future pandemics, crucial for public health, economic stability and national security.

The mRNA Multiplier: Making the UK a World Leader in a Vital Health Technology

| 20th December 2024

Owning the Longevity Challenge: The Rewards of an Evergreen Society

| 27th November 2024

Prevent, Protect, Cooperate: Why the World Needs the Global Pandemic Agreement

| 24th May 2024

How Demand Forecasting, Supply Planning and Market Shaping Can Deliver a New Model for Global Vaccine Manufacturing

| 23rd May 2023

From Stop-Start to “Always On”: Investing in Everyday Disease Prevention

| 19th May 2023

GHSC comment: G20 Health Working Groups

| 31st January 2023

A Vision for Global Health: The Digital Toolbox Needed to Deliver One Shot

| 1st January 2023

Prevention Is Better Than Cure - A New Model For UK Vaccine Delivery

| 8th December 2022

African Governments Need a Post-Covid Plan to Protect Essential Health Services

| 23rd November 2022

Why We Need a Transformative Approach to Data Analysis and Genomic Surveillance for Outbreak Preparedness

| 15th November 2022

The Africa Vaccines Programme: Utilising Data-Management Tools for Vaccine Delivery

| 4th November 2022